Proto Labs Inc: Form 10-Q for the period ended Sep 30, 2014
Filed with the SEC on Nov 4, 2014 and accepted by EDGAR at Nov 4, 2014, 12:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-07-01 to 2014-09-30 | $54.6m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2014-01-01 to 2014-09-30 | $153.5m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-07-01 to 2014-09-30 | $21.5m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2014-01-01 to 2014-09-30 | $58.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2014-07-01 to 2014-09-30 | $33.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2014-01-01 to 2014-09-30 | $94.8m | us-gaap:GrossProfit |
| Research and development | 3 months2014-07-01 to 2014-09-30 | $4.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2014-01-01 to 2014-09-30 | $11.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2014-07-01 to 2014-09-30 | $15.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-01-01 to 2014-09-30 | $45.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2014-07-01 to 2014-09-30 | $5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2014-01-01 to 2014-09-30 | $14.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-07-01 to 2014-09-30 | $10.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-01-01 to 2014-09-30 | $31.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-07-01 to 2014-09-30 | $0.40 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-01-01 to 2014-09-30 | $1.20 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-07-01 to 2014-09-30 | $0.40 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2014-01-01 to 2014-09-30 | $1.23 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-07-01 to 2014-09-30 | 26,200,741 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-01-01 to 2014-09-30 | 26,109,539 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-01-01 to 2014-09-30 | $40.0m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2014-01-01 to 2014-09-30 | $35.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-09-30 | $34.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-09-30 | $97.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-09-30 | $279.4m | us-gaap:Assets |
| Current liabilities | At period end2014-09-30 | $20.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-09-30 | $25.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-09-30 | $254.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-14-019440. Last ingested by Listed: Nov 4, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.